Valion Bio (VBIO) Other Accumulated Expenses (2021 - 2026)
Valion Bio (VBIO) posted Other Accumulated Expenses of $1.83 million for Q2 2026, up 211.9% from $587,000 a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio's Other Accumulated Expenses came in at $376,000, up 184.8% from FY2024.
- Annual Other Accumulated Expenses shows a four-year compound annual growth rate of 8.9% (FY2021 to FY2025).
- In prior years, Valion Bio's Other Accumulated Expenses was $132,000 in FY2024 (-73.3%), $495,000 in FY2023 (+26.3%), $392,000 in FY2022 (+46.8%) and $267,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2021.
- On a year-over-year basis, Other Accumulated Expenses increased in five of the last seven quarters, with growth averaging 91.3%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2025, with growth of 304.8%; the weakest was Q4 2024, with a decline of 73.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Valion Bio | 339,352.00 | -19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | 173,000.00 |
| Jun 30, 2025 | 587,000.00 |
| Mar 31, 2025 | 303,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 495,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 297,000.00 |
| Dec 31, 2022 | 392,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 304,000.00 |
| Dec 31, 2021 | 267,000.00 |
API Access
Valion Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();